Circulation:瑞金医院闫小响团队发现心肌肥厚和心力衰竭关键驱动信号

2022-04-03 MedSci原创 MedSci原创 发表于威斯康星

上海交通大学医学院附属瑞金医院心脏内科闫小响教授研究团队在心肌能量代谢调控心力衰竭的发生发展方面取得新进展,研究成果以“DYRK1B-STAT3通过抑制线粒体能量代谢驱动心肌肥厚和心力衰竭

上海交通大学医学院附属瑞金医院心脏内科闫小响教授研究团队在心肌能量代谢调控心力衰竭的发生发展方面取得新进展,研究成果以“DYRK1B-STAT3通过抑制线粒体能量代谢驱动心肌肥厚和心力衰竭进展(DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics)”为题,于2022年3月3日在《循环》(Circulation)杂志上在线发表。

心力衰竭是各种心脏疾病的终末阶段,尽管规范化治疗能改善心衰患者的临床症状,并降低了主要血管事件的发生,但治疗心力衰竭仍是临床面临的一个难题。因此,深入探索心衰发生过程中的机制和干预靶点,进一步改善患者的远期预后具有重要意义。

研究表明,蛋白激酶系统在心肌能量代谢障碍致心力衰竭的发生中发挥重要作用。闫小响研究团队通过DYRK1B心脏特异性转基因和敲除小鼠,发现DYRK1B过表达直接导致自发性心力衰竭;而DYRK1B敲除明显抑制TAC诱导的心肌肥厚和心力衰竭。

Figure 2.

DYRK1B overexpression results in heart failure.

并揭示DYRK1B通过与STAT3结合,促进其705位点的磷酸化和细胞核内聚集,进而负向调控心肌组织中PGC-1α的表达,最终导致心肌细胞线粒体能量生成障碍和心力衰竭的发生。

Figure 3.

DYRK1B deletion attenuates TAC-indued cardiac hypertrophy and heart failure.

为推动该成果的临床转化,团队分别使用DYRK1B抑制剂和STAT3抑制剂探究其潜在临床应用价值,发现STAT3抑制剂(S31-201)能够显著减轻DYRK1B过表达引起的线粒体能量代谢受损和心功能不全,而DYRK1B抑制剂(AZ191)减轻TAC手术引起的STAT3激活、线粒体能量受损和心室肥厚。

Figure 4.

DYRK1B drives cardiac dysfunction by impairing mitochondrial bioenergetics.

研究证明DYRK1B-STAT3信号轴通过抑制PGC-1α的表达致线粒体能量代谢受损,进而参与心力衰竭的发生,为调控心肌细胞能量代谢防治心力衰竭提供新的理论支持。

Figure 7.

 STAT3 inhibition rescues DYRK1B overexpression-induced heart failure.

 

 DYRK1B调控心肌线粒体能量代谢参与心力衰竭的机制示意图

原始出处:

Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, Zhang H, Fan Q, Huang C, Xie H, Lu L, Shen W, Ning G, Wang J, Zhang R, Chen K, Yan X.DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics.Circulation. 2022 Mar 15;145(11):829-846

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-05-05 148a60abm39暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-04 test-rml

    厉害厉害👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-04 最黄的大芒果

    签到

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-04 1212ba38m22暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-04 学医无涯

    学习一下

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-03 医者仁者

    厉害!!#心肌肥厚#,可能成为治疗靶点吧

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1217122, encodeId=67e1121e122c7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cd35319553, createdName=148a60abm39暂无昵称, createdTime=Thu May 05 17:21:06 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208481, encodeId=4090120848194, content=厉害厉害👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5305494196, createdName=test-rml, createdTime=Mon Apr 04 08:40:22 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208597, encodeId=433f120859efc, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e15563207, createdName=最黄的大芒果, createdTime=Mon Apr 04 19:32:35 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208490, encodeId=669f1208490ee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Mon Apr 04 09:33:17 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208476, encodeId=63d312084e6c7, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Mon Apr 04 07:19:03 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208454, encodeId=1de81208454a8, content=厉害!!<a href='/topic/show?id=fd7b5132eb2' target=_blank style='color:#2F92EE;'>#心肌肥厚#</a>,可能成为治疗靶点吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51327, encryptionId=fd7b5132eb2, topicName=心肌肥厚)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Apr 03 22:58:49 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208453, encodeId=9baf120845328, content=签到, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbd31357750, createdName=jiangying28, createdTime=Sun Apr 03 22:56:17 CST 2022, time=2022-04-03, status=1, ipAttribution=)]
    2022-04-03 jiangying28

    签到

    0

相关资讯

Circ Res:花生四烯酸可预测心力衰竭患者的预后并指导治疗

AA评分可预测急性失代偿性HF患者的死亡,抑制sEH可作为治疗HF的一个治疗目标。

EHJ:COVID-19大流行对心力衰竭中肺动脉压监测的影响

在 2019 年冠状病毒病 (COVID-19) 大流行期间,心力衰竭 (HF) 事件发生率的重要变化已被广泛报道,但很少有数据说明这些变化的潜在原因;GUIDE-HF 研究中检查了几种可能性。

JAHA:老年人心脏结构和功能与糖尿病相关的死亡或心力衰竭风险的关系

在老年人的混血儿队列中,心脏结构和功能异常部分解释了与糖尿病相关的事件风险增加。

JACC:盐皮质激素受体拮抗剂对恩格列净治疗射血分数保留的心衰患者的效果的影响

达格列净在减少慢性心衰患者的主要终点方面不受是否同时服用盐皮质激素受体拮抗剂的影响。

Eur Heart J:中年血钠水平与心力衰竭风险

中年时血钠水平高于142mmol/L是左心室肥大和心力衰竭的危险因素。终生保持良好的水合作用可以减缓心脏功能的下降并降低心力衰竭的患病率。